Abstract
Experiments were carried out to elucidate the characteristics of regulation of cyclic AMP levels in intact myocardial cells. For this purpose, the influence of isoproterenol, a nonselective cyclic nucleotide phosphodiesterase (PDE) inhibitor 3-isobutyl-l-methylxanthine (IBMX) and carbachol on cyclic AMP levels was investigated in isolated rat cardiac myocytes. The extent of cyclic AMP accumulation induced by isoproterenol was much less than that produced by IBMX: submaximal concentrations of isoproterenol and IBMX elevated the cyclic AMP level 2.4- and 4.8-fold of the control level, respectively. Both agents in combination increased the cyclic AMP level markedly 48-fold. Carbachol inhibited the cyclic AMP accumulation induced by isoproterenol, IBMX and their combination by 30%, 60% and 80% of the respective response. The extent of inhibition produced by carbachol of the cyclic AMP accumulation induced by IBMX + isoproterenol was smaller than that caused by propranolol, and carbachol produced only a marginal additional inhibitory action to that of propranolol, implying that carbachol does not affect the process of cyclic AMP degradation. The present findings indicate that in intact cardiac myocytes the rate of cyclic AMP degradation catalyzed by PDE may be a crucial process of cyclic AMP turnover. This view is supported by the observations that the inhibitory action of carbachol on the effect of isoproterenol was less than that on the effect of IBMX, and that the inhibitory action of carbachol was markedly enhanced by the simultaneous presence of IBMX. (Mol Cell Biochem 119: 195–201, 1993)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Biegon RL, Epstein PM, Pappano AJ: Muscarinic antagonism of the effects of a phosphodiesterase inhibitor (methylisobutylxan-thine) in embryonic chick ventricle. J Pharmacol Exp Ther 215: 348–356, 1980
Hollenberg M, Carriere S, Barger AC: Biphasic action of ace-tylcholine on ventricular myocardium. Circ Res 16: 527–536, 1965
Löffelholz K, Pappano AJ: The parasympathetic neuroeffector junction of the heart. Pharmacol Rev 37: 1–24, 1985
Levy MN: Sympathetic-parasympathetic interactions in the heart. Circ Res 29: 437–445, 1971
Birnbaumer L, Codina J, Sunyer T, Hildebrandt JD, Sekura RD, Cerione RA, Lefkowitz RJ, Caron MG: Dual coupling mechanisms in the regulation of cAMP formation. In: AM Gotto Jr and BW O’Malley (eds). The role of receptors in biology and medicine. Raven Press, New York, 1986, p 193–211
Gilman AG: G proteins: transducers of receptor-regulated signals. Ann Rev Biochem 56: 615–649, 1987
Ui M, Katada T, Maruyama T, Kurose H, Yajima M, Tamura M, Nakamura T, Nogimori K: Islet-activating protein, pertussis toxin: a specific uncoupler of receptor-mediated inhibition of adenylate cyclase. Adv Cyclic Nucleotide Protein Phosphorylation Res 17: 145–151, 1984
Thompson WJ, Pratt ML, Strada SJ: Biochemical properties of high-affinity cyclic AMP phosphodiesterases. Adv Cyclic Protein Phosphorylation Res 16: 137–148, 1984
Weishaar RE, Kobylarz-Singer D, Reiser JA, Wright CD, Cornicelli J, Panek R: Cyclic nucleotide phosphodiesterases in the circulatory system. Biochemical, pharmacological, and functional characteristics. Adv Cyclic Protein Phosphorylation Res 25: 249–269, 1992
Powell T, Twist VW: A rapid technique for the isolation and purification of adult cardiac muscle cells having respiratory control and a tolerance to calcium. Biochem Biophys Res Commun 72: 327–333, 1976
Katada T, Ui M: Islet activating protein: enhanced insulin secretion and cyclic AMP accumulation in pancreatic islets due to activation of native calcium ionophores. J Biol Chem 254: 469–479, 1979
Murad F, Chi YM, Rail TW, Sutherland EW: Adenyl cyclase: II. The effect of catecholamines and choline esters on the formation of adenosine-3′-5′-monophosphate by preparations from cardiac muscle and liver. J Biol Chem 237: 1233–1238, 1962
Lindemann JP, Watanabe AM: Muscariniccholinergicinhibition of β-adrenergic stimulation of phospholamban phosphorylation and Ca2+ transport in guinea pig ventricles. J Biol Chem 260: 13122–13129, 1985
Brown BS, Poison JB, Krzanowski JJ, Wiggins JA: Influence of isoproterenol and methylisobutylxanthine on the contractile and cyclic nucleotide effects of methacholine in isolated rat atria. J Pharmacol Exp Ther 212: 325–332, 1980
Endoh M: Dual inhibition of myocardial function through muscarinic and adenosine receptors in the mammalian heart. J Appl Cardiol 2: 213–230, 1987
Chasin M, Harris DN: Inhibitors and activators of cyclic nucleotide phosphodiesterase. Adv Cyclic Nucleotide Res 7: 225–264, 1976
Korth M: Effects of several phosphodiesterase-inhibitors on guinea-pig myocardium. Naunyn-Schmiedeberg’s Arch Pharmacol 302: 77–86, 1978
Weishaar RE, Cain MH, Bristol JA: A new generation of phosphodiesterase inhibitors: Multiple molecular forms of phosphodiesterase and the potential for drug selectivity. J Med Chem 28: 537–545, 1985
Meeker RB, Harden TK: Muscarinic cholinergic receptor-mediated activation of phosphodiesterase. Mol Pharmacol 22: 310–319, 1982
Parsons WJ, Ramkumar V, Stiles GL: Isobutylmethylxanthine stimulates adenylate cyclase by blocking the inhibitory regulatory protein, Gi. Mol Pharmacol 34: 37–41, 1988
Lavan BE, Lakey T, Houselay MD: Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form. Biochem Pharmacol 38: 4123–4136, 1989
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Katano, Y., Endoh, M. (1993). Cyclic AMP Metabolism in Intact Rat Ventricular Cardiac Myocytes: Interaction of Carbachol with Isoproterenol and 3-Isobutyl-L-Methylxanthine. In: Yazaki, Y., Mochizuki, S. (eds) Cellular Function and Metabolism. Developments in Molecular and Cellular Biochemistry, vol 9. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3078-7_26
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3078-7_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6344-6
Online ISBN: 978-1-4615-3078-7
eBook Packages: Springer Book Archive